Aropotin is a hematopoietic agent, prescribed for anemia in people with chronic kidney failure. It helps in the formation of red blood cells by the bone marrow.
Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology. Authorised by the European Medicines Agency on 28 August 2007, it stimulates erythropoiesis and is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.
Features
- Epoetin Alfa